Clarissa Buranasombati, | |
1487 E Chevy Chase Dr, Glendale, CA 91206-4008 | |
(818) 638-0135 | |
Not Available |
Full Name | Clarissa Buranasombati |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 1487 E Chevy Chase Dr, Glendale, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1518730332 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 88861 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Clarissa Buranasombati, 2729 Winter St, Los Angeles, CA 90033-2630 Ph: () - | Clarissa Buranasombati, 1487 E Chevy Chase Dr, Glendale, CA 91206-4008 Ph: (818) 638-0135 |
News Archive
Seventy-four percent of men treated with a combination of radiation seed implants and external beam radiation therapy for prostate cancer are cured of their disease 15 years following their treatment, according to a study released in the International Journal of Radiation Oncology-Biology-Physics, the official journal of ASTRO.
Researchers have found that more than half the cases of non-hereditary or sporadic schizophrenia are caused by "new" protein-altering gene mutations. These mutations are new genetic errors that appear in patients but not in either of their parents, the researchers explained in the report published in the Aug. 7 online edition of the journal Nature Genetics.
A novel, accelerator-driven method could produce nuclides for targeted alpha therapy of cancer in practically unlimited amounts, overcoming current obstacles for its wider use due to a limited production of alpha-emitters. The JRC and the Conseil Européen pour la Recherche Nucléaire have embarked to explore the potential of the jointly proposed method.
The U.S. Food and Drug Administration today approved the Argus II Retinal Prosthesis System, the first implanted device to treat adult patients with advanced retinitis pigmentosa (RP).
InVivo Therapeutics Holdings Corp., a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), and Geisinger Health System today announced a research collaboration to conduct a preclinical study using InVivo's injectable biocompatible hydrogel for the treatment of chronic pain caused by peripheral nerve compression.
› Verified 8 days ago
Rosemary Kahale, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 125 N Central Ave, Glendale, CA 91203 Phone: 818-637-2758 | |
Annie Ahhyun Kim, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3943 San Fernando Rd, Glendale, CA 91204 Phone: 818-549-2270 | |
Dr. Linda Kalamkeryan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 600 W Stocker St, 105, Glendale, CA 91202 Phone: 818-433-8379 | |
Dr. Jane Kyun Lee, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1509 Wilson Ter, Glendale, CA 91206 Phone: 818-409-8000 | |
Anna Arutunyan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1122 E Broadway, Glendale, CA 91205 Phone: 818-547-0170 | |
Dr. Monica Natalia Macias, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1509 Wilson Terrace, Glendale, CA 91206 Phone: 818-409-8140 | |
Arash Akmal, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3452 Country Club Dr, Glendale, CA 91208 Phone: 310-463-7326 |